![Hilary Webber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Hilary Webber
Sociétés | Poste | Début | Fin |
---|---|---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Président | - | - |
Historique de carrière de Hilary Webber
Anciens postes connus de Hilary Webber
Sociétés | Poste | Début | Fin |
---|---|---|---|
CANNASOUTH LIMITED | Directeur/Membre du Conseil | - | 01/01/2024 |
Independent Dir/Board Member | - | 01/01/2024 |
Statistiques
Internationale
Nouvelle-Zélande | 3 |
Opérationnelle
Chairman | 1 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CANNASOUTH LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Bourse
- Insiders
- Hilary Webber
- Expérience